round button
Leave a message

سوق الأجهزة الطبية القابلة للزرع النشطة في أمريكا الشمالية – اتجاهات الصناعة والتوقعات حتى عام 2028

Request for TOC طلب جدول المحتويات Speak to Analyst تحدث إلى المحلل Buy Now اشتري الآن Inquire Before Buying استفسر قبل Free Sample Report تقرير عينة مجاني

سوق الأجهزة الطبية القابلة للزرع النشطة في أمريكا الشمالية – اتجاهات الصناعة والتوقعات حتى عام 2028

  • Medical Devices
  • Published Report
  • Oct 2021
  • North America
  • 350 الصفحات
  • عدد الجداول: 70
  • عدد الأرقام: 38

سوق الأجهزة الطبية القابلة للزرع في أمريكا الشمالية، حسب المنتج (أجهزة علاج إعادة مزامنة القلب (CRT-D)، أجهزة تنظيم ضربات القلب القابلة للزرع، أجهزة تنظيم ضربات القلب القابلة للزرع، غرسات العين، أجهزة تحفيز الأعصاب، أجهزة السمع القابلة للزرع النشطة، أجهزة مساعدة البطين، أجهزة مراقبة القلب القابلة للزرع/مسجلات الحلقة القابلة للإدخال، العلاج الإشعاعي، أجهزة مراقبة الجلوكوز القابلة للزرع، غرسات القدم المتدلية، غرسات الكتف، مضخات التسريب القابلة للزرع، والملحقات القابلة للزرع)، نوع الجراحة (الطرق الجراحية التقليدية والجراحة الأقل توغلاً)، الإجراء (الأوعية الدموية العصبية، القلب والأوعية الدموية، السمع، وغيرها)، المستخدم النهائي (المستشفيات، العيادات المتخصصة، مراكز الجراحة الخارجية، العيادات)، الدولة (الولايات المتحدة وكندا والمكسيك) اتجاهات الصناعة والتوقعات حتى عام 2028

سوق الأجهزة الطبية القابلة للزرع النشطة في أمريكا الشمالية

تحليل السوق والرؤى: سوق الأجهزة الطبية القابلة للزرع النشطة في أمريكا الشمالية

من المتوقع أن يكتسب سوق الأجهزة الطبية القابلة للزرع النشطة في أمريكا الشمالية نموًا كبيرًا في الفترة المتوقعة من 2021 إلى 2028. تحلل شركة Data Bridge Market Research أن السوق ينمو بمعدل نمو سنوي مركب بنسبة 7.9٪ في الفترة المتوقعة من 2021 إلى 2028 ومن المتوقع أن يصل إلى 12،665.68 مليون دولار أمريكي بحلول عام 2028. زيادة أنشطة البحث والتطوير في صناعة الرعاية الصحية وزيادة الإنفاق على الرعاية الصحية هي المحركات الرئيسية التي تعزز نمو السوق في الفترة المتوقعة. وفرت الزيادة في التمويل والاستثمار الحكومي فرصة للشركات لإطلاق المزيد من المنتجات. ومع ذلك، فإن التكلفة العالية وسحب المنتج من الأجهزة القابلة للزرع يشكلان تحديًا كبيرًا للسوق.

الأجهزة الطبية القابلة للزرع النشطة هي أجهزة تعمل بالطاقة يتم إدخالها إلى جسم المريض عن طريق إجراء جراحي وتهدف إلى البقاء في جسم المريض بعد العملية الجراحية.

إن التقدم المتزايد في التكنولوجيا يدفع نمو سوق الأجهزة الطبية القابلة للزرع النشطة في أمريكا الشمالية. ومن المتوقع أن تعمل الاستثمارات المتزايدة في أنشطة تطوير المنتجات الجديدة عبر المناطق الجغرافية الرئيسية على دفع الطلب على الأجهزة الطبية القابلة للزرع النشطة في السنوات القادمة. في حين أن تكلفة العلاج والتأثير الضار له يعوقان نمو السوق.

يقدم تقرير سوق الأجهزة الطبية القابلة للزرع النشطة في أمريكا الشمالية تفاصيل عن حصة السوق والتطورات الجديدة وتحليل خط أنابيب المنتجات وتأثير اللاعبين المحليين والمحليين في السوق وتحليل الفرص من حيث جيوب الإيرادات الناشئة والتغييرات في لوائح السوق وموافقات المنتجات والقرارات الاستراتيجية وإطلاق المنتجات والتوسعات الجغرافية والابتكارات التكنولوجية في السوق. لفهم التحليل وسيناريو السوق، اتصل بنا للحصول على موجز محلل، وسيساعدك فريقنا في إنشاء حل لتأثير الإيرادات لتحقيق هدفك المنشود.

سوق الأجهزة الطبية القابلة للزرع النشطة في أمريكا الشمالية

نطاق سوق الأجهزة الطبية القابلة للزرع النشطة في أمريكا الشمالية وحجم السوق

North America Active medical implantable devices market is segmented on the basis of product, surgery type, procedure, and end users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the North America active medical implantable devices market is segmented into Cardiac Resynchronization Therapy Devices (CRT-D), implantable cardioverter defibrillators, implantable cardiac pacemakers, eye implants, neurostimulators, active implantable hearing devices, ventricular assist devices, implantable heart monitors/ insertable loop recorders, brachytheraphy, implantable glucose monitors, dropped foot implants, shoulder implants, implantable infusion pumps and implantable accessories. In 2021, Cardiac Resynchronization Therapy Devices (CRT-D) segment is expected to dominate the market owing to increase in the demand for implantable devices stoked by their efficient results.
  • On the basis of surgery type the North America active medical implantable devices market is segmented into traditional surgical methods and minimally invasive surgery. In 2021, traditional surgical methods segment is expected to dominate the market as it have reasonable cost and expense of the treatment.
  • On the basis of procedure, the North America active medical implantable devices market is segmented into neurovascular, cardiovascular, hearing and others. In 2021, cardiovascular is expected to dominate the market with the increase in cardiovascular disease.
  • On the basis of end-users, the North America active medical implantable devices market is segmented into hospitals, specialty clinics, ambulatory surgical centers and clinics. In 2021, hospital segment is expected to dominate the market due growing demand of active medical implantable devices

North America Active Medical Implantable Devices Market Country Level Analysis

The North America active medical implantable devices market is analyzed and market size information is provided on the basis of product, surgery type, procedure, end users.

The countries covered in the active medical implantable devices market report are the U.S., Canada, and Mexico.

Active medical implantable devices segment in North America region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing research development for enhancing the product quality. The U.S is leading the growth of the North America active medical implantable devices market and cardiovascular segment is dominating in this country due to increasing prevalence of diseases in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Increase in advancement and technology for new product development are boosting the market growth of active medical implantable devices growth

North America active medical implantable devices market also provides you with detailed market analysis for every country growth in active medical implantable devices industry with active medical implantable devices drugs sales, impact of advancement in the active medical implantable devices technology and changes in regulatory scenarios with their support for the market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Active Medical Implantable Devices Market Share Analysis

Active medical implantable devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to active medical implantable devices market.

The major companies which are dealing in the North America active medical implantable devices market are NeuroPace, Inc., Axonics, Inc., Stimwave LLC, NEVRO CORP, Second Sight, BIOTRONIK, ABIOMED, Boston Scientific Corporation, Medtronic, Abbott, Eckert & Ziegler., Sonova, Zhejiang Nurotron Biotechnology Co., Ltd, Demant A/S, Cochlear Ltd, Microson, Oticon Medical, Nano Retina, GluSense, MED-EL Medical Electronics among others.

Several product launches and agreements are also initiated by the companies worldwide, which are also accelerating the growth of the active medical implantable devices market.

For instance,

  • In March 2021, Medline industries, Inc announced that they have been awarded a prime vendor contract to serve as the exclusive supply vendor for Windsor Lane Health Care, an Ohio-based long-term care facility which has increased its supply chain in United States.
  • في يناير 2020، أعلنت شركة Medline Industries, Inc. عن الاستحواذ على Médi-Sélect، وهي شركة توزيع اللوازم الطبية وطب الأسنان ومقرها مدينة كيبيك للانضمام إلى عمليات Medline Canada التي زادت من شبكة التوزيع وسلسلة التوريد الخاصة بها


SKU-

احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم

  • لوحة معلومات تحليل البيانات التفاعلية
  • لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
  • إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
  • تحليل المنافسين باستخدام لوحة معلومات تفاعلية
  • آخر الأخبار والتحديثات وتحليل الاتجاهات
  • استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
طلب التجريبي

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET APPLICATION COVERAGE GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 INDUSTRY INSIGHTS

5 REGULATORY ANALYSIS

5.1 REGULATION IN EUROPE

5.2 REGULATION IN U.S.

5.3 REGULATION IN CANADA

5.4 REGULATION IN CHINA

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 TECHNOLOGICAL ADVANCEMENT

6.1.2 INCREASING BURDEN OF CARDIOVASCULAR DISEASES, NEUROLOGICAL DISORDERS AND HEARING DISORDERS

6.1.3 INCREASING FDA APPROVAL

6.1.4 RISING AWARENESS FOR MEDICAL IMPLANTS

6.2 RESTRAINTS

6.2.1 HIGH COST OF MEDICAL IMPLANTS

6.2.2 INCREASING RISK OF DEVELOPING INFECTION AND OTHER COMPLICATIONS

6.3 OPPORTUNITIES

6.3.1 INCREASE IN DEMAND FOR MINIMALLY INVASIVE SURGERIES

6.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS

6.3.3 INCREASE IN THE GERIATRIC POPULATION

6.3.4 RISING HEALTHCARE INFRASTRUCTURE

6.4 CHALLENGES

6.4.1 INCREASING PRODUCT RECALL

6.4.2 SUPPLY CHAIN DISRUPTION DUT TO COVID-19 PANDEMIC OUTBREAK

7 IMPACT OF COVID-19

7.1 IMPACT ON PRICE

7.2 IMPACT ON DEMAND

7.3 IMPACT ON SUPPLY

7.4 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS

7.5 CONCLUSION

8 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D)

8.3 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

8.3.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

8.3.1.1 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

8.3.1.2 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)/ CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-DS)

8.3.1.3 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

8.3.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

8.4 IMPLANTABLE CARDIAC PACEMAKERS

8.4.1 DUAL CHAMBER PACEMAKERS

8.4.2 BIVENTRICULAR PACEMAKERS

8.4.3 SINGLE CHAMBER PACEMAKERS

8.5 EYE IMPLANTS

8.6 NEUROSTIMULATORS

8.6.1 SPINAL CORD STIMULATORS

8.6.2 DEEP BRAIN STIMULATORS

8.6.3 BLADDER STIMULATORS

8.6.4 GASTRIC NERVE STIMULATORS

8.6.5 SACRAL NERVE STIMULATORS

8.6.6 LIMB FUNCTION STIMULATORS

8.6.7 VAGUS STIMULATORS

8.6.8 OTHERS

8.7 ACTIVE IMPLANTABLE HEARING DEVICES

8.8 VENTRICULAR ASSIST DEVICES

8.9 IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS

8.1 BRACHYTHERAPY

8.11 IMPLANTABLE GLUCOSE MONITORS

8.12 DROPPED FOOT IMPLANTS

8.13 SHOULDER IMPLANTS

8.14 IMPLANTABLE INFUSION PUMPS

8.15 IMPLANTABLE ACCESSORIES

8.15.1 LEAD

8.15.2 ELECTRODES

8.15.3 ADAPTORS

8.15.4 OTHERS

9 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE

9.1 OVERVIEW

9.2 TRADITIONAL SURGICAL METHODS

9.3 MINIMALLY INVASIVE SURGERY

10 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE

10.1 OVERVIEW

10.2 CARDIOVASCULAR

10.3 NEUROLOGICAL

10.4 HEARING

10.5 OTHERS

11 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER

11.1 OVERVIEW

11.2 HOSPITALS

11.3 AMBULATORY SURGICAL CENTERS

11.4 SPECIALIZED CLINICS

11.5 CLINICS

12 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 COMPANY PROFILE

14.1 MEDTRONIC

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 ABBOTT

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 BOSTON SCIENTIFIC CORPORATION

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 COCHLEAR LTD

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENT

14.5 ABIOMED

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENTS

14.6 AXONICS, INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENTS

14.7 BIOTRONIK SE & CO. KG

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 DEMANT A/S

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENT

14.9 ECKERT & ZIEGLER.

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT DEVELOPMENTS

14.1 GLUSENSE

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 MED-EL MEDICAL ELECTRONICS

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 MICROSON

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 NANO RETINA

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 NEUROPACE, INC.

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT DEVELOPMENT

14.15 NEVRO CORP.

14.15.1 COMPANY SNAPSHOT

14.15.2 REVENUE ANALYSIS

14.15.3 PRODUCT PORTFOLIO

14.15.4 RECENT DEVELOPMENTS

14.15.5 RECENT DEVELOPMENTS

14.16 OTICON MEDICAL

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

14.17 SECOND SIGHT

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENT

14.18 SONOVA

14.18.1 COMPANY SNAPSHOT

14.18.2 REVENUE ANALYSIS

14.18.3 PRODUCT PORTFOLIO

14.18.4 RECENT DEVELOPMENTS

14.19 STIMWAVE LLC

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENT

14.2 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

List of Table

TABLE 1 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 2 NORTH AMERICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D) IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA EYE IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA ACTIVE IMPLANTABLE HEARING DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA VENTRICULAR ASSIST DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA BRACHYTHERAPY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA IMPLANTABLE GLUCOSE MONITORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA DROPPED FOOT IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA SHOULDER IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA IMPLANTABLE INFUSION PUMPS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA TRADITIONAL SURGICAL METHODS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA CARDIOVASCULAR IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA NEUROLOGICAL IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA HEARING IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA OTHERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA HOSPITALS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA SPECIALIZED CLINICS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA CLINICS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 44 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 45 U.S. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 46 U.S. TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 47 U.S. IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 48 U.S. NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 49 U.S. IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 50 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 51 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 52 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 54 CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 55 CANADA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 56 CANADA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 57 CANADA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 58 CANADA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 59 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 60 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 61 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 62 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 63 MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 64 MEXICO TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 65 MEXICO IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 66 MEXICO NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 67 MEXICO IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 68 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 69 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 70 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

List of Figure

FIGURE 1 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 SURGERY TYPE LIFELINE CURVE

FIGURE 7 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION

FIGURE 12 THE INCREASE IN DEMAND FOR ACTIVE MEDICAL IMPLANTABLE DEVICES EXPECTED TO DRIVE THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 CARDIOVASCULAR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN 2021 & 2028

FIGURE 14 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET

FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLION)

FIGURE 17 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2020

FIGURE 18 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2019-2028 (USD MILLION)

FIGURE 19 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, CAGR (2021-2028)

FIGURE 20 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 21 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2020

FIGURE 22 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2019-2028 (USD MILLION)

FIGURE 23 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, CAGR (2021-2028)

FIGURE 24 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE

FIGURE 25 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2020

FIGURE 26 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2019-2028 (USD MILLION)

FIGURE 27 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)

FIGURE 28 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE

FIGURE 29 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2020

FIGURE 30 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 31 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, CAGR (2021-2028)

FIGURE 32 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 33 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SNAPSHOT (2020)

FIGURE 34 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020)

FIGURE 35 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 36 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 37 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT (2021-2028)

FIGURE 38 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY SHARE 2020 (%)

View Detailed Information Right Arrow

منهجية البحث

يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.

منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.

التخصيص متاح

تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.

Frequently Asked Questions

The North America Active Medical Implantable Devices Market size will be worth USD 12,665.68 million by 2028.
The North America Active Medical Implantable Devices Market growth rate will be 7.9% by 2028.
The Increasing R&D activities in the healthcare industry and increase in healthcare expenditure are the growth drivers of the North America Active Medical Implantable Devices Market.
The product, surgery type, procedure, and end users are the factors on which the North America Active Medical Implantable Devices Market research is based.
The major companies in the North America Active Medical Implantable Devices Market are NeuroPace, Inc., Axonics, Inc., Stimwave LLC, NEVRO CORP, Second Sight, BIOTRONIK, ABIOMED, Boston Scientific Corporation, Medtronic, Abbott, Eckert & Ziegler., Sonova, Zhejiang Nurotron Biotechnology Co., Ltd, Demant A/S, Cochlear Ltd, Microson, Oticon Medical, Nano Retina, GluSense, MED-EL Medical Electronics.
a